nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—coronary artery disease—type 2 diabetes mellitus	0.295	0.626	CtDrD
Furosemide—hypertension—type 2 diabetes mellitus	0.176	0.374	CtDrD
Furosemide—ABCC2—type 2 diabetes mellitus	0.12	0.722	CbGaD
Furosemide—ALB—type 2 diabetes mellitus	0.0464	0.278	CbGaD
Furosemide—ALB—Gliclazide—type 2 diabetes mellitus	0.0205	0.108	CbGbCtD
Furosemide—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0204	0.108	CbGbCtD
Furosemide—ALB—Repaglinide—type 2 diabetes mellitus	0.0192	0.102	CbGbCtD
Furosemide—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0182	0.0965	CbGbCtD
Furosemide—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0161	0.0851	CbGbCtD
Furosemide—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0155	0.0821	CbGbCtD
Furosemide—ABCC2—Glyburide—type 2 diabetes mellitus	0.0143	0.0758	CbGbCtD
Furosemide—ALB—Valsartan—type 2 diabetes mellitus	0.0142	0.0752	CbGbCtD
Furosemide—ALB—Nateglinide—type 2 diabetes mellitus	0.0132	0.0699	CbGbCtD
Furosemide—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0105	0.0554	CbGbCtD
Furosemide—SLC22A6—Losartan—type 2 diabetes mellitus	0.00957	0.0507	CbGbCtD
Furosemide—ALB—Glyburide—type 2 diabetes mellitus	0.00891	0.0472	CbGbCtD
Furosemide—ALB—Losartan—type 2 diabetes mellitus	0.00815	0.0432	CbGbCtD
Furosemide—Indapamide—KCNQ1—type 2 diabetes mellitus	0.00175	0.844	CrCbGaD
Furosemide—CA1—nerve—type 2 diabetes mellitus	0.000843	0.0389	CbGeAlD
Furosemide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.000697	0.0321	CbGeAlD
Furosemide—CA4—nerve—type 2 diabetes mellitus	0.000659	0.0304	CbGeAlD
Furosemide—CA7—kidney—type 2 diabetes mellitus	0.000561	0.0259	CbGeAlD
Furosemide—SLCO2A1—islet of Langerhans—type 2 diabetes mellitus	0.000547	0.0253	CbGeAlD
Furosemide—CA5A—liver—type 2 diabetes mellitus	0.000533	0.0246	CbGeAlD
Furosemide—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.000491	0.0227	CbGeAlD
Furosemide—PGD—islet of Langerhans—type 2 diabetes mellitus	0.000488	0.0225	CbGeAlD
Furosemide—SLC12A1—nephron tubule—type 2 diabetes mellitus	0.000478	0.022	CbGeAlD
Furosemide—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000463	0.0214	CbGeAlD
Furosemide—SLCO2A1—nephron tubule—type 2 diabetes mellitus	0.000441	0.0203	CbGeAlD
Furosemide—SLC22A11—kidney—type 2 diabetes mellitus	0.000432	0.0199	CbGeAlD
Furosemide—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.000421	0.0194	CbGeAlD
Furosemide—SLC12A1—kidney—type 2 diabetes mellitus	0.00042	0.0194	CbGeAlD
Furosemide—PGD—retina—type 2 diabetes mellitus	0.000417	0.0192	CbGeAlD
Furosemide—SLC12A1—cortex of kidney—type 2 diabetes mellitus	0.000409	0.0189	CbGeAlD
Furosemide—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000396	0.0183	CbGeAlD
Furosemide—PGD—nephron tubule—type 2 diabetes mellitus	0.000393	0.0181	CbGeAlD
Furosemide—SLCO2A1—kidney—type 2 diabetes mellitus	0.000387	0.0179	CbGeAlD
Furosemide—SLCO2A1—pancreas—type 2 diabetes mellitus	0.000385	0.0178	CbGeAlD
Furosemide—SLCO2A1—cortex of kidney—type 2 diabetes mellitus	0.000377	0.0174	CbGeAlD
Furosemide—CA12—kidney—type 2 diabetes mellitus	0.000365	0.0168	CbGeAlD
Furosemide—PGD—cardiovascular system—type 2 diabetes mellitus	0.000353	0.0163	CbGeAlD
Furosemide—SLCO2A1—adipose tissue—type 2 diabetes mellitus	0.000349	0.0161	CbGeAlD
Furosemide—PGD—kidney—type 2 diabetes mellitus	0.000345	0.0159	CbGeAlD
Furosemide—PGD—cortex of kidney—type 2 diabetes mellitus	0.000336	0.0155	CbGeAlD
Furosemide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000334	0.0154	CbGeAlD
Furosemide—CA5B—pancreas—type 2 diabetes mellitus	0.000325	0.015	CbGeAlD
Furosemide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000319	0.0147	CbGeAlD
Furosemide—PGD—adipose tissue—type 2 diabetes mellitus	0.000311	0.0144	CbGeAlD
Furosemide—CA14—liver—type 2 diabetes mellitus	0.000295	0.0136	CbGeAlD
Furosemide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000295	0.0136	CbGeAlD
Furosemide—CA5B—adipose tissue—type 2 diabetes mellitus	0.000295	0.0136	CbGeAlD
Furosemide—CA1—kidney—type 2 diabetes mellitus	0.000289	0.0133	CbGeAlD
Furosemide—CA1—pancreas—type 2 diabetes mellitus	0.000287	0.0132	CbGeAlD
Furosemide—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000277	0.0128	CbGeAlD
Furosemide—SLC22A11—liver—type 2 diabetes mellitus	0.000273	0.0126	CbGeAlD
Furosemide—ABCC2—nephron tubule—type 2 diabetes mellitus	0.00027	0.0125	CbGeAlD
Furosemide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000265	0.0122	CbGeAlD
Furosemide—CA1—adipose tissue—type 2 diabetes mellitus	0.00026	0.012	CbGeAlD
Furosemide—CA4—nephron tubule—type 2 diabetes mellitus	0.000257	0.0119	CbGeAlD
Furosemide—SLCO2A1—liver—type 2 diabetes mellitus	0.000245	0.0113	CbGeAlD
Furosemide—SLC22A8—kidney—type 2 diabetes mellitus	0.000244	0.0112	CbGeAlD
Furosemide—ABCC2—kidney—type 2 diabetes mellitus	0.000238	0.011	CbGeAlD
Furosemide—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000237	0.0109	CbGeAlD
Furosemide—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000232	0.0107	CbGeAlD
Furosemide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000231	0.0106	CbGeAlD
Furosemide—CA2—retina—type 2 diabetes mellitus	0.000226	0.0104	CbGeAlD
Furosemide—CA4—kidney—type 2 diabetes mellitus	0.000226	0.0104	CbGeAlD
Furosemide—SLC22A5—retina—type 2 diabetes mellitus	0.000223	0.0103	CbGeAlD
Furosemide—CA4—cortex of kidney—type 2 diabetes mellitus	0.00022	0.0101	CbGeAlD
Furosemide—PGD—liver—type 2 diabetes mellitus	0.000218	0.0101	CbGeAlD
Furosemide—CA2—nephron tubule—type 2 diabetes mellitus	0.000213	0.00983	CbGeAlD
Furosemide—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.00021	0.00967	CbGeAlD
Furosemide—CA4—adipose tissue—type 2 diabetes mellitus	0.000203	0.00939	CbGeAlD
Furosemide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000191	0.00883	CbGeAlD
Furosemide—CA2—kidney—type 2 diabetes mellitus	0.000187	0.00864	CbGeAlD
Furosemide—CA2—pancreas—type 2 diabetes mellitus	0.000186	0.00858	CbGeAlD
Furosemide—SLC22A5—kidney—type 2 diabetes mellitus	0.000184	0.0085	CbGeAlD
Furosemide—CA1—liver—type 2 diabetes mellitus	0.000183	0.00842	CbGeAlD
Furosemide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000182	0.00841	CbGeAlD
Furosemide—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000179	0.00827	CbGeAlD
Furosemide—Indapamide—CYP3A4—type 2 diabetes mellitus	0.000174	0.0838	CrCbGaD
Furosemide—CA2—adipose tissue—type 2 diabetes mellitus	0.000169	0.00778	CbGeAlD
Furosemide—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000166	0.00766	CbGeAlD
Furosemide—ALB—liver—type 2 diabetes mellitus	0.00016	0.0074	CbGeAlD
Furosemide—ABCC2—liver—type 2 diabetes mellitus	0.00015	0.00693	CbGeAlD
Furosemide—Bumetanide—PTGS2—type 2 diabetes mellitus	0.000149	0.0721	CrCbGaD
Furosemide—CA2—liver—type 2 diabetes mellitus	0.000118	0.00546	CbGeAlD
Furosemide—SLC22A5—liver—type 2 diabetes mellitus	0.000116	0.00537	CbGeAlD
Furosemide—Erythema—Losartan—type 2 diabetes mellitus	5.61e-05	0.000554	CcSEcCtD
Furosemide—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	5.59e-05	0.000553	CcSEcCtD
Furosemide—Headache—Glipizide—type 2 diabetes mellitus	5.58e-05	0.000552	CcSEcCtD
Furosemide—Shock—Valsartan—type 2 diabetes mellitus	5.57e-05	0.00055	CcSEcCtD
Furosemide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	5.55e-05	0.000549	CcSEcCtD
Furosemide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	5.54e-05	0.000548	CcSEcCtD
Furosemide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	5.53e-05	0.000547	CcSEcCtD
Furosemide—Flatulence—Losartan—type 2 diabetes mellitus	5.52e-05	0.000546	CcSEcCtD
Furosemide—Anaemia—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000544	CcSEcCtD
Furosemide—Dizziness—Glimepiride—type 2 diabetes mellitus	5.5e-05	0.000544	CcSEcCtD
Furosemide—Skin disorder—Valsartan—type 2 diabetes mellitus	5.49e-05	0.000543	CcSEcCtD
Furosemide—Dysgeusia—Losartan—type 2 diabetes mellitus	5.49e-05	0.000543	CcSEcCtD
Furosemide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	5.48e-05	0.000542	CcSEcCtD
Furosemide—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.48e-05	0.000542	CcSEcCtD
Furosemide—Agitation—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000541	CcSEcCtD
Furosemide—Somnolence—Gliclazide—type 2 diabetes mellitus	5.47e-05	0.000541	CcSEcCtD
Furosemide—Urticaria—Glyburide—type 2 diabetes mellitus	5.45e-05	0.000539	CcSEcCtD
Furosemide—Skin disorder—Orlistat—type 2 diabetes mellitus	5.43e-05	0.000537	CcSEcCtD
Furosemide—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.42e-05	0.000536	CcSEcCtD
Furosemide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000534	CcSEcCtD
Furosemide—Anorexia—Valsartan—type 2 diabetes mellitus	5.39e-05	0.000533	CcSEcCtD
Furosemide—Muscle spasms—Losartan—type 2 diabetes mellitus	5.39e-05	0.000533	CcSEcCtD
Furosemide—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.38e-05	0.000532	CcSEcCtD
Furosemide—Vertigo—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000529	CcSEcCtD
Furosemide—Headache—Pioglitazone—type 2 diabetes mellitus	5.35e-05	0.000529	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	5.34e-05	0.000528	CcSEcCtD
Furosemide—Leukopenia—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000527	CcSEcCtD
Furosemide—Visual impairment—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000526	CcSEcCtD
Furosemide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.32e-05	0.000526	CcSEcCtD
Furosemide—Fatigue—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000525	CcSEcCtD
Furosemide—Nausea—Glipizide—type 2 diabetes mellitus	5.29e-05	0.000523	CcSEcCtD
Furosemide—Vomiting—Glimepiride—type 2 diabetes mellitus	5.29e-05	0.000523	CcSEcCtD
Furosemide—Hypotension—Valsartan—type 2 diabetes mellitus	5.29e-05	0.000523	CcSEcCtD
Furosemide—Vision blurred—Losartan—type 2 diabetes mellitus	5.28e-05	0.000522	CcSEcCtD
Furosemide—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.27e-05	0.000521	CcSEcCtD
Furosemide—Constipation—Gliclazide—type 2 diabetes mellitus	5.27e-05	0.000521	CcSEcCtD
Furosemide—Pain—Gliclazide—type 2 diabetes mellitus	5.27e-05	0.000521	CcSEcCtD
Furosemide—Rash—Glimepiride—type 2 diabetes mellitus	5.24e-05	0.000518	CcSEcCtD
Furosemide—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.24e-05	0.000518	CcSEcCtD
Furosemide—Rash—Sitagliptin—type 2 diabetes mellitus	5.23e-05	0.000517	CcSEcCtD
Furosemide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.22e-05	0.000516	CcSEcCtD
Furosemide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000516	CcSEcCtD
Furosemide—Headache—Glimepiride—type 2 diabetes mellitus	5.21e-05	0.000515	CcSEcCtD
Furosemide—Headache—Sitagliptin—type 2 diabetes mellitus	5.19e-05	0.000513	CcSEcCtD
Furosemide—Anaemia—Losartan—type 2 diabetes mellitus	5.18e-05	0.000512	CcSEcCtD
Furosemide—Agitation—Losartan—type 2 diabetes mellitus	5.15e-05	0.000509	CcSEcCtD
Furosemide—Tinnitus—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000509	CcSEcCtD
Furosemide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.13e-05	0.000508	CcSEcCtD
Furosemide—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.08e-05	0.000502	CcSEcCtD
Furosemide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.07e-05	0.000502	CcSEcCtD
Furosemide—Shock—Metformin—type 2 diabetes mellitus	5.07e-05	0.000501	CcSEcCtD
Furosemide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.05e-05	0.0005	CcSEcCtD
Furosemide—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.05e-05	0.0005	CcSEcCtD
Furosemide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.04e-05	0.000499	CcSEcCtD
Furosemide—Vertigo—Losartan—type 2 diabetes mellitus	5.04e-05	0.000498	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000498	CcSEcCtD
Furosemide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.03e-05	0.000498	CcSEcCtD
Furosemide—Somnolence—Valsartan—type 2 diabetes mellitus	5.03e-05	0.000497	CcSEcCtD
Furosemide—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.02e-05	0.000496	CcSEcCtD
Furosemide—Leukopenia—Losartan—type 2 diabetes mellitus	5.02e-05	0.000496	CcSEcCtD
Furosemide—Skin disorder—Metformin—type 2 diabetes mellitus	5e-05	0.000495	CcSEcCtD
Furosemide—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000493	CcSEcCtD
Furosemide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.98e-05	0.000492	CcSEcCtD
Furosemide—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.96e-05	0.00049	CcSEcCtD
Furosemide—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.00049	CcSEcCtD
Furosemide—Nausea—Glimepiride—type 2 diabetes mellitus	4.94e-05	0.000488	CcSEcCtD
Furosemide—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000488	CcSEcCtD
Furosemide—Nausea—Sitagliptin—type 2 diabetes mellitus	4.92e-05	0.000487	CcSEcCtD
Furosemide—Asthenia—Glyburide—type 2 diabetes mellitus	4.92e-05	0.000487	CcSEcCtD
Furosemide—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000486	CcSEcCtD
Furosemide—Anorexia—Metformin—type 2 diabetes mellitus	4.91e-05	0.000486	CcSEcCtD
Furosemide—Urticaria—Gliclazide—type 2 diabetes mellitus	4.89e-05	0.000484	CcSEcCtD
Furosemide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.88e-05	0.000483	CcSEcCtD
Furosemide—Fatigue—Valsartan—type 2 diabetes mellitus	4.88e-05	0.000482	CcSEcCtD
Furosemide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.87e-05	0.000481	CcSEcCtD
Furosemide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.87e-05	0.000481	CcSEcCtD
Furosemide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000481	CcSEcCtD
Furosemide—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.86e-05	0.000481	CcSEcCtD
Furosemide—Pruritus—Glyburide—type 2 diabetes mellitus	4.85e-05	0.00048	CcSEcCtD
Furosemide—Constipation—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000478	CcSEcCtD
Furosemide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.83e-05	0.000477	CcSEcCtD
Furosemide—Fatigue—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000477	CcSEcCtD
Furosemide—Hypotension—Metformin—type 2 diabetes mellitus	4.81e-05	0.000476	CcSEcCtD
Furosemide—Erythema—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000475	CcSEcCtD
Furosemide—Malnutrition—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000475	CcSEcCtD
Furosemide—Shock—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000473	CcSEcCtD
Furosemide—Pain—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000473	CcSEcCtD
Furosemide—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.77e-05	0.000472	CcSEcCtD
Furosemide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000471	CcSEcCtD
Furosemide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.000471	CcSEcCtD
Furosemide—Rash—Bromocriptine—type 2 diabetes mellitus	4.73e-05	0.000468	CcSEcCtD
Furosemide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.73e-05	0.000467	CcSEcCtD
Furosemide—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000467	CcSEcCtD
Furosemide—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000465	CcSEcCtD
Furosemide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000465	CcSEcCtD
Furosemide—Headache—Bromocriptine—type 2 diabetes mellitus	4.7e-05	0.000465	CcSEcCtD
Furosemide—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.69e-05	0.000464	CcSEcCtD
Furosemide—Dry mouth—Losartan—type 2 diabetes mellitus	4.67e-05	0.000462	CcSEcCtD
Furosemide—Anorexia—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000458	CcSEcCtD
Furosemide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.63e-05	0.000457	CcSEcCtD
Furosemide—Paraesthesia—Metformin—type 2 diabetes mellitus	4.63e-05	0.000457	CcSEcCtD
Furosemide—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000457	CcSEcCtD
Furosemide—Confusional state—Losartan—type 2 diabetes mellitus	4.61e-05	0.000456	CcSEcCtD
Furosemide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.61e-05	0.000456	CcSEcCtD
Furosemide—Somnolence—Metformin—type 2 diabetes mellitus	4.58e-05	0.000453	CcSEcCtD
Furosemide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.58e-05	0.000452	CcSEcCtD
Furosemide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.57e-05	0.000452	CcSEcCtD
Furosemide—Hypotension—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000449	CcSEcCtD
Furosemide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.54e-05	0.000449	CcSEcCtD
Furosemide—Shock—Losartan—type 2 diabetes mellitus	4.5e-05	0.000445	CcSEcCtD
Furosemide—Urticaria—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000444	CcSEcCtD
Furosemide—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.49e-05	0.000444	CcSEcCtD
Furosemide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.48e-05	0.000443	CcSEcCtD
Furosemide—Decreased appetite—Metformin—type 2 diabetes mellitus	4.48e-05	0.000443	CcSEcCtD
Furosemide—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.47e-05	0.000442	CcSEcCtD
Furosemide—Nausea—Bromocriptine—type 2 diabetes mellitus	4.46e-05	0.000441	CcSEcCtD
Furosemide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.45e-05	0.00044	CcSEcCtD
Furosemide—Fatigue—Metformin—type 2 diabetes mellitus	4.44e-05	0.000439	CcSEcCtD
Furosemide—Urticaria—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000439	CcSEcCtD
Furosemide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.42e-05	0.000437	CcSEcCtD
Furosemide—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.42e-05	0.000437	CcSEcCtD
Furosemide—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.42e-05	0.000437	CcSEcCtD
Furosemide—Asthenia—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000437	CcSEcCtD
Furosemide—Agitation—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000437	CcSEcCtD
Furosemide—Constipation—Metformin—type 2 diabetes mellitus	4.41e-05	0.000436	CcSEcCtD
Furosemide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000432	CcSEcCtD
Furosemide—Anorexia—Losartan—type 2 diabetes mellitus	4.36e-05	0.000431	CcSEcCtD
Furosemide—Vomiting—Glyburide—type 2 diabetes mellitus	4.36e-05	0.000431	CcSEcCtD
Furosemide—Pruritus—Gliclazide—type 2 diabetes mellitus	4.36e-05	0.000431	CcSEcCtD
Furosemide—Rash—Glyburide—type 2 diabetes mellitus	4.32e-05	0.000428	CcSEcCtD
Furosemide—Somnolence—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000427	CcSEcCtD
Furosemide—Dermatitis—Glyburide—type 2 diabetes mellitus	4.32e-05	0.000427	CcSEcCtD
Furosemide—Vertigo—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000427	CcSEcCtD
Furosemide—Leukopenia—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000425	CcSEcCtD
Furosemide—Headache—Glyburide—type 2 diabetes mellitus	4.3e-05	0.000425	CcSEcCtD
Furosemide—Hypotension—Losartan—type 2 diabetes mellitus	4.28e-05	0.000423	CcSEcCtD
Furosemide—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.25e-05	0.00042	CcSEcCtD
Furosemide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000418	CcSEcCtD
Furosemide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.21e-05	0.000417	CcSEcCtD
Furosemide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.21e-05	0.000417	CcSEcCtD
Furosemide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000415	CcSEcCtD
Furosemide—Fatigue—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000414	CcSEcCtD
Furosemide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.17e-05	0.000412	CcSEcCtD
Furosemide—Pain—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000411	CcSEcCtD
Furosemide—Constipation—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000411	CcSEcCtD
Furosemide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.12e-05	0.000407	CcSEcCtD
Furosemide—Paraesthesia—Losartan—type 2 diabetes mellitus	4.11e-05	0.000406	CcSEcCtD
Furosemide—Urticaria—Metformin—type 2 diabetes mellitus	4.09e-05	0.000405	CcSEcCtD
Furosemide—Nausea—Glyburide—type 2 diabetes mellitus	4.07e-05	0.000403	CcSEcCtD
Furosemide—Abdominal pain—Metformin—type 2 diabetes mellitus	4.07e-05	0.000403	CcSEcCtD
Furosemide—Dizziness—Gliclazide—type 2 diabetes mellitus	4.07e-05	0.000403	CcSEcCtD
Furosemide—Somnolence—Losartan—type 2 diabetes mellitus	4.07e-05	0.000402	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000402	CcSEcCtD
Furosemide—Asthenia—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000401	CcSEcCtD
Furosemide—Asthenia—Orlistat—type 2 diabetes mellitus	4.01e-05	0.000397	CcSEcCtD
Furosemide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000396	CcSEcCtD
Furosemide—Pruritus—Valsartan—type 2 diabetes mellitus	4e-05	0.000396	CcSEcCtD
Furosemide—Dry mouth—Ramipril—type 2 diabetes mellitus	4e-05	0.000396	CcSEcCtD
Furosemide—Decreased appetite—Losartan—type 2 diabetes mellitus	3.98e-05	0.000393	CcSEcCtD
Furosemide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000393	CcSEcCtD
Furosemide—Confusional state—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000391	CcSEcCtD
Furosemide—Pruritus—Orlistat—type 2 diabetes mellitus	3.95e-05	0.000391	CcSEcCtD
Furosemide—Fatigue—Losartan—type 2 diabetes mellitus	3.94e-05	0.00039	CcSEcCtD
Furosemide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000388	CcSEcCtD
Furosemide—Vomiting—Gliclazide—type 2 diabetes mellitus	3.91e-05	0.000387	CcSEcCtD
Furosemide—Constipation—Losartan—type 2 diabetes mellitus	3.91e-05	0.000387	CcSEcCtD
Furosemide—Pain—Losartan—type 2 diabetes mellitus	3.91e-05	0.000387	CcSEcCtD
Furosemide—Rash—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000384	CcSEcCtD
Furosemide—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000384	CcSEcCtD
Furosemide—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.87e-05	0.000383	CcSEcCtD
Furosemide—Urticaria—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000382	CcSEcCtD
Furosemide—Shock—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000382	CcSEcCtD
Furosemide—Headache—Gliclazide—type 2 diabetes mellitus	3.86e-05	0.000381	CcSEcCtD
Furosemide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.85e-05	0.00038	CcSEcCtD
Furosemide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.00038	CcSEcCtD
Furosemide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.00038	CcSEcCtD
Furosemide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.84e-05	0.00038	CcSEcCtD
Furosemide—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000378	CcSEcCtD
Furosemide—Skin disorder—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000377	CcSEcCtD
Furosemide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000375	CcSEcCtD
Furosemide—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.77e-05	0.000373	CcSEcCtD
Furosemide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.74e-05	0.00037	CcSEcCtD
Furosemide—Dizziness—Valsartan—type 2 diabetes mellitus	3.74e-05	0.00037	CcSEcCtD
Furosemide—Anorexia—Ramipril—type 2 diabetes mellitus	3.74e-05	0.00037	CcSEcCtD
Furosemide—Dizziness—Orlistat—type 2 diabetes mellitus	3.7e-05	0.000366	CcSEcCtD
Furosemide—Asthenia—Metformin—type 2 diabetes mellitus	3.7e-05	0.000365	CcSEcCtD
Furosemide—Hypotension—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000362	CcSEcCtD
Furosemide—Nausea—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.000362	CcSEcCtD
Furosemide—Pruritus—Metformin—type 2 diabetes mellitus	3.64e-05	0.00036	CcSEcCtD
Furosemide—Urticaria—Losartan—type 2 diabetes mellitus	3.63e-05	0.000359	CcSEcCtD
Furosemide—Abdominal pain—Losartan—type 2 diabetes mellitus	3.62e-05	0.000358	CcSEcCtD
Furosemide—Body temperature increased—Losartan—type 2 diabetes mellitus	3.62e-05	0.000358	CcSEcCtD
Furosemide—Vomiting—Valsartan—type 2 diabetes mellitus	3.6e-05	0.000356	CcSEcCtD
Furosemide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.58e-05	0.000354	CcSEcCtD
Furosemide—Rash—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000353	CcSEcCtD
Furosemide—Dermatitis—Valsartan—type 2 diabetes mellitus	3.56e-05	0.000352	CcSEcCtD
Furosemide—Vomiting—Orlistat—type 2 diabetes mellitus	3.55e-05	0.000351	CcSEcCtD
Furosemide—Headache—Valsartan—type 2 diabetes mellitus	3.54e-05	0.00035	CcSEcCtD
Furosemide—Diarrhoea—Metformin—type 2 diabetes mellitus	3.52e-05	0.000349	CcSEcCtD
Furosemide—Rash—Orlistat—type 2 diabetes mellitus	3.52e-05	0.000349	CcSEcCtD
Furosemide—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000348	CcSEcCtD
Furosemide—Dermatitis—Orlistat—type 2 diabetes mellitus	3.52e-05	0.000348	CcSEcCtD
Furosemide—Headache—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000346	CcSEcCtD
Furosemide—Asthenia—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000345	CcSEcCtD
Furosemide—Somnolence—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000345	CcSEcCtD
Furosemide—Pruritus—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.00034	CcSEcCtD
Furosemide—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000337	CcSEcCtD
Furosemide—Dizziness—Metformin—type 2 diabetes mellitus	3.41e-05	0.000337	CcSEcCtD
Furosemide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000335	CcSEcCtD
Furosemide—Fatigue—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000334	CcSEcCtD
Furosemide—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.37e-05	0.000333	CcSEcCtD
Furosemide—Nausea—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000332	CcSEcCtD
Furosemide—Constipation—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000332	CcSEcCtD
Furosemide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000329	CcSEcCtD
Furosemide—Nausea—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000328	CcSEcCtD
Furosemide—Asthenia—Losartan—type 2 diabetes mellitus	3.28e-05	0.000325	CcSEcCtD
Furosemide—Vomiting—Metformin—type 2 diabetes mellitus	3.28e-05	0.000324	CcSEcCtD
Furosemide—Rash—Metformin—type 2 diabetes mellitus	3.25e-05	0.000321	CcSEcCtD
Furosemide—Dermatitis—Metformin—type 2 diabetes mellitus	3.25e-05	0.000321	CcSEcCtD
Furosemide—Pruritus—Losartan—type 2 diabetes mellitus	3.24e-05	0.00032	CcSEcCtD
Furosemide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.23e-05	0.00032	CcSEcCtD
Furosemide—Headache—Metformin—type 2 diabetes mellitus	3.23e-05	0.000319	CcSEcCtD
Furosemide—Dizziness—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000318	CcSEcCtD
Furosemide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000317	CcSEcCtD
Furosemide—Diarrhoea—Losartan—type 2 diabetes mellitus	3.13e-05	0.00031	CcSEcCtD
Furosemide—Urticaria—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000308	CcSEcCtD
Furosemide—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000307	CcSEcCtD
Furosemide—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000307	CcSEcCtD
Furosemide—Vomiting—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.000306	CcSEcCtD
Furosemide—Rash—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000303	CcSEcCtD
Furosemide—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000303	CcSEcCtD
Furosemide—Nausea—Metformin—type 2 diabetes mellitus	3.06e-05	0.000303	CcSEcCtD
Furosemide—Headache—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000301	CcSEcCtD
Furosemide—Dizziness—Losartan—type 2 diabetes mellitus	3.03e-05	0.000299	CcSEcCtD
Furosemide—Vomiting—Losartan—type 2 diabetes mellitus	2.91e-05	0.000288	CcSEcCtD
Furosemide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000286	CcSEcCtD
Furosemide—Nausea—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000286	CcSEcCtD
Furosemide—Rash—Losartan—type 2 diabetes mellitus	2.88e-05	0.000285	CcSEcCtD
Furosemide—Dermatitis—Losartan—type 2 diabetes mellitus	2.88e-05	0.000285	CcSEcCtD
Furosemide—Headache—Losartan—type 2 diabetes mellitus	2.87e-05	0.000283	CcSEcCtD
Furosemide—Asthenia—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000278	CcSEcCtD
Furosemide—Pruritus—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000274	CcSEcCtD
Furosemide—Nausea—Losartan—type 2 diabetes mellitus	2.72e-05	0.000269	CcSEcCtD
Furosemide—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000265	CcSEcCtD
Furosemide—Dizziness—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000257	CcSEcCtD
Furosemide—Vomiting—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000247	CcSEcCtD
Furosemide—Rash—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000245	CcSEcCtD
Furosemide—Dermatitis—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000244	CcSEcCtD
Furosemide—Headache—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000243	CcSEcCtD
Furosemide—Nausea—Ramipril—type 2 diabetes mellitus	2.33e-05	0.00023	CcSEcCtD
Furosemide—CA5A—Metabolism—NOS3—type 2 diabetes mellitus	6.43e-06	0.000131	CbGpPWpGaD
Furosemide—ALB—Metabolism—AK1—type 2 diabetes mellitus	6.4e-06	0.000131	CbGpPWpGaD
Furosemide—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	6.36e-06	0.00013	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.36e-06	0.00013	CbGpPWpGaD
Furosemide—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	6.36e-06	0.00013	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.36e-06	0.00013	CbGpPWpGaD
Furosemide—CA12—Metabolism—INS—type 2 diabetes mellitus	6.35e-06	0.00013	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX1—type 2 diabetes mellitus	6.34e-06	0.000129	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	6.32e-06	0.000129	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—type 2 diabetes mellitus	6.28e-06	0.000128	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—type 2 diabetes mellitus	6.28e-06	0.000128	CbGpPWpGaD
Furosemide—CA9—Metabolism—GNB3—type 2 diabetes mellitus	6.27e-06	0.000128	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.27e-06	0.000128	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.26e-06	0.000128	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	6.24e-06	0.000127	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	6.24e-06	0.000127	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.23e-06	0.000127	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.23e-06	0.000127	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3R1—type 2 diabetes mellitus	6.21e-06	0.000127	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—type 2 diabetes mellitus	6.21e-06	0.000127	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD36—type 2 diabetes mellitus	6.17e-06	0.000126	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAT—type 2 diabetes mellitus	6.16e-06	0.000126	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	6.15e-06	0.000125	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	6.12e-06	0.000125	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	6.12e-06	0.000125	CbGpPWpGaD
Furosemide—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	6.1e-06	0.000125	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.09e-06	0.000124	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.08e-06	0.000124	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.06e-06	0.000124	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.05e-06	0.000123	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGT—type 2 diabetes mellitus	6.05e-06	0.000123	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	6.04e-06	0.000123	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.01e-06	0.000123	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	6.01e-06	0.000123	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	6.01e-06	0.000123	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—type 2 diabetes mellitus	6.01e-06	0.000123	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	6.01e-06	0.000123	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARA—type 2 diabetes mellitus	5.98e-06	0.000122	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOB—type 2 diabetes mellitus	5.98e-06	0.000122	CbGpPWpGaD
Furosemide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	5.94e-06	0.000121	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—type 2 diabetes mellitus	5.92e-06	0.000121	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	5.9e-06	0.00012	CbGpPWpGaD
Furosemide—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	5.9e-06	0.00012	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	5.9e-06	0.00012	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	5.9e-06	0.00012	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	5.89e-06	0.00012	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—type 2 diabetes mellitus	5.89e-06	0.00012	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	5.88e-06	0.00012	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.87e-06	0.00012	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	5.86e-06	0.00012	CbGpPWpGaD
Furosemide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	5.85e-06	0.000119	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—type 2 diabetes mellitus	5.82e-06	0.000119	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	5.82e-06	0.000119	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGT—type 2 diabetes mellitus	5.8e-06	0.000118	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	5.77e-06	0.000118	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	5.75e-06	0.000117	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.75e-06	0.000117	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	5.74e-06	0.000117	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	5.72e-06	0.000117	CbGpPWpGaD
Furosemide—CA9—Metabolism—LPL—type 2 diabetes mellitus	5.71e-06	0.000117	CbGpPWpGaD
Furosemide—ALB—Metabolism—HBA2—type 2 diabetes mellitus	5.7e-06	0.000116	CbGpPWpGaD
Furosemide—ALB—Metabolism—G6PC—type 2 diabetes mellitus	5.7e-06	0.000116	CbGpPWpGaD
Furosemide—ALB—Metabolism—ND1—type 2 diabetes mellitus	5.7e-06	0.000116	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	5.7e-06	0.000116	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.7e-06	0.000116	CbGpPWpGaD
Furosemide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	5.7e-06	0.000116	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—type 2 diabetes mellitus	5.68e-06	0.000116	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—type 2 diabetes mellitus	5.68e-06	0.000116	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	5.61e-06	0.000115	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	5.6e-06	0.000114	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	5.6e-06	0.000114	CbGpPWpGaD
Furosemide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	5.59e-06	0.000114	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	5.57e-06	0.000114	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	5.57e-06	0.000114	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	5.57e-06	0.000114	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	5.57e-06	0.000114	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—type 2 diabetes mellitus	5.56e-06	0.000113	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCGR—type 2 diabetes mellitus	5.52e-06	0.000113	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	5.51e-06	0.000112	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	5.49e-06	0.000112	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	5.49e-06	0.000112	CbGpPWpGaD
Furosemide—PGD—Disease—SRC—type 2 diabetes mellitus	5.48e-06	0.000112	CbGpPWpGaD
Furosemide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	5.46e-06	0.000112	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—type 2 diabetes mellitus	5.44e-06	0.000111	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—type 2 diabetes mellitus	5.43e-06	0.000111	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	5.38e-06	0.00011	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.36e-06	0.000109	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	5.35e-06	0.000109	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	5.32e-06	0.000108	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.3e-06	0.000108	CbGpPWpGaD
Furosemide—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	5.21e-06	0.000106	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYTB—type 2 diabetes mellitus	5.21e-06	0.000106	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	5.16e-06	0.000105	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	5.14e-06	0.000105	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	5.09e-06	0.000104	CbGpPWpGaD
Furosemide—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	5.08e-06	0.000104	CbGpPWpGaD
Furosemide—CA4—Metabolism—INS—type 2 diabetes mellitus	5.06e-06	0.000103	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.05e-06	0.000103	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	5.04e-06	0.000103	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	4.99e-06	0.000102	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	4.95e-06	0.000101	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—type 2 diabetes mellitus	4.9e-06	0.0001	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—type 2 diabetes mellitus	4.89e-06	9.97e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—INS—type 2 diabetes mellitus	4.85e-06	9.9e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—STAR—type 2 diabetes mellitus	4.85e-06	9.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	4.85e-06	9.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACACA—type 2 diabetes mellitus	4.85e-06	9.89e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.85e-06	9.89e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	4.82e-06	9.85e-05	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—type 2 diabetes mellitus	4.81e-06	9.81e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	4.8e-06	9.8e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.8e-06	9.8e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—type 2 diabetes mellitus	4.79e-06	9.77e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	4.74e-06	9.68e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	4.74e-06	9.67e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	4.73e-06	9.66e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.65e-06	9.49e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—INS—type 2 diabetes mellitus	4.65e-06	9.49e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	4.65e-06	9.48e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CBS—type 2 diabetes mellitus	4.65e-06	9.48e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—type 2 diabetes mellitus	4.64e-06	9.47e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOB—type 2 diabetes mellitus	4.6e-06	9.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	4.47e-06	9.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—COX2—type 2 diabetes mellitus	4.47e-06	9.13e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—type 2 diabetes mellitus	4.45e-06	9.08e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.44e-06	9.06e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	4.44e-06	9.06e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	4.39e-06	8.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.39e-06	8.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	4.32e-06	8.82e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—UCP3—type 2 diabetes mellitus	4.32e-06	8.82e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—UCP2—type 2 diabetes mellitus	4.32e-06	8.82e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—type 2 diabetes mellitus	4.26e-06	8.7e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	4.25e-06	8.68e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.25e-06	8.68e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.19e-06	8.55e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.18e-06	8.52e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—type 2 diabetes mellitus	4.17e-06	8.52e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	4.17e-06	8.51e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.16e-06	8.48e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	4.12e-06	8.41e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.12e-06	8.41e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—INS—type 2 diabetes mellitus	4.09e-06	8.35e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	4.08e-06	8.33e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.08e-06	8.33e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PCK1—type 2 diabetes mellitus	4.06e-06	8.29e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	4.06e-06	8.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4e-06	8.16e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.98e-06	8.13e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	3.96e-06	8.08e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	3.9e-06	7.96e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	3.89e-06	7.94e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	3.86e-06	7.87e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	3.8e-06	7.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HK1—type 2 diabetes mellitus	3.8e-06	7.76e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	3.8e-06	7.75e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—type 2 diabetes mellitus	3.75e-06	7.65e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	3.73e-06	7.61e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.72e-06	7.6e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	3.69e-06	7.54e-05	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—type 2 diabetes mellitus	3.69e-06	7.54e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	3.67e-06	7.5e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	3.67e-06	7.5e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCKR—type 2 diabetes mellitus	3.67e-06	7.5e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPA—type 2 diabetes mellitus	3.67e-06	7.5e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	3.64e-06	7.43e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.59e-06	7.32e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	3.59e-06	7.32e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	3.54e-06	7.22e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.53e-06	7.21e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	3.52e-06	7.19e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	3.47e-06	7.09e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	3.43e-06	7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.42e-06	6.98e-05	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—type 2 diabetes mellitus	3.41e-06	6.95e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.36e-06	6.85e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.35e-06	6.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.31e-06	6.76e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	3.28e-06	6.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	3.27e-06	6.68e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.15e-06	6.43e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	3.06e-06	6.24e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	3.04e-06	6.21e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	3.04e-06	6.2e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	3.04e-06	6.19e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	2.99e-06	6.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTR—type 2 diabetes mellitus	2.99e-06	6.11e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	2.96e-06	6.04e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—type 2 diabetes mellitus	2.96e-06	6.04e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	2.94e-06	5.99e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.92e-06	5.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LIPC—type 2 diabetes mellitus	2.92e-06	5.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HBA1—type 2 diabetes mellitus	2.92e-06	5.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCK—type 2 diabetes mellitus	2.92e-06	5.96e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	2.9e-06	5.92e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.89e-06	5.9e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—type 2 diabetes mellitus	2.85e-06	5.82e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	2.85e-06	5.81e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CETP—type 2 diabetes mellitus	2.82e-06	5.75e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	2.76e-06	5.64e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	2.76e-06	5.64e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	2.76e-06	5.63e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	2.76e-06	5.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	2.62e-06	5.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	2.62e-06	5.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	2.62e-06	5.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CTGF—type 2 diabetes mellitus	2.57e-06	5.24e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	2.56e-06	5.22e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	2.55e-06	5.2e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.51e-06	5.12e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	2.49e-06	5.09e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	2.46e-06	5.02e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	2.39e-06	4.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	2.37e-06	4.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	2.37e-06	4.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	2.31e-06	4.71e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.3e-06	4.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	2.27e-06	4.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCG—type 2 diabetes mellitus	2.27e-06	4.63e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SRC—type 2 diabetes mellitus	2.04e-06	4.16e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	2.04e-06	4.16e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.99e-06	4.06e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.96e-06	3.99e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.96e-06	3.99e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	1.96e-06	3.99e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.95e-06	3.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.92e-06	3.92e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	1.88e-06	3.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.87e-06	3.81e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	1.82e-06	3.72e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	1.81e-06	3.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPL—type 2 diabetes mellitus	1.78e-06	3.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.74e-06	3.56e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.74e-06	3.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.69e-06	3.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.67e-06	3.41e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	3.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.6e-06	3.27e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.57e-06	3.21e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.52e-06	3.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1.5e-06	3.06e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—type 2 diabetes mellitus	1.49e-06	3.05e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.48e-06	3.01e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.3e-06	2.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—INS—type 2 diabetes mellitus	1.28e-06	2.6e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.27e-06	2.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.12e-06	2.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.12e-06	2.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.02e-06	2.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—type 2 diabetes mellitus	5.14e-07	1.05e-05	CbGpPWpGaD
